Transplantation of SNAP-treated adipose tissue-derived stem cells improves cardiac function and induces neovascularization after myocardium infarct in rats

Experimental and Molecular Pathology

Volumn 90, Issue 2, 2011, Pages 149-156

  Berardi, Gel R M ^a   Rebelatto, Carmen K ^a   Tavares, Heloísa F ^a   Ingberman, Max ^b   Shigunov, Patrícia ^c   Barchiki, Fabiane ^a   Aguiar, Alessandra M ^c   Miyague, Nelson I ^a   Francisco, Julio C ^a   Correa, Alejandro ^c   Senegaglia, Alexandra C ^a   Suss, Paula Hansen ^a   Moutinho, José A ^a   Sotomaior, Vanessa S ^a   Nakao, Lia S ^a,b   Brofman, Paulo S ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c INSTITUTO CARLOS CHAGAS   (Brazil)

Author keywords

Adipose derived stem cells; Cardiomyogenesis; Ejection fraction; Neovascularization; Nitric oxide; SNAP

Indexed keywords

CELL PROTEIN; CYCLIC GMP; GLUTATHIONE; GLUTATHIONE DISULFIDE; N ACETYL S NITROSOPENICILLAMINE; TROPONIN C; TROPONIN T; VON WILLEBRAND FACTOR;

ADIPOSE TISSUE CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; HEART BLOOD VESSEL; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HUMAN; HUMAN CELL; NITROSATION; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE;

ADIPOSE TISSUE; ANIMALS; GLUTATHIONE; GREEN FLUORESCENT PROTEINS; HEART; HEART FUNCTION TESTS; INTRACELLULAR SPACE; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; NITROSATION; RATS; RATS, WISTAR; S-NITROSO-N-ACETYLPENICILLAMINE; STEM CELL TRANSPLANTATION; STEM CELLS; STROKE VOLUME; TROPONIN; VON WILLEBRAND FACTOR;

RATTUS;

EID: 78650871132     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.11.005     Document Type: Article

References (46)

1. Al-Radi O.O., et al. Cardiac cell transplantation: closer to bedside. Ann. Thorac. Surg. 2003, 75:S674-S677.
2. Anversa P., et al. Primitive cells and tissue regeneration. Circ. Res. 2003, 92:579-582.
3. Boyle A.J., et al. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step. Circulation 2006, 114:339-352.
4. Caplan A.I. Why are MSCs therapeutic? New data: new insight. J. Pathol. 2009, 217:318-324.
5. Chamberlain G., et al. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
6. Dai W., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005, 112:214-223.
7. Dominici M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
8. Fraser J.K., et al. Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3(Suppl 1):S33-S37.
9. Freyman T., et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur. Heart J. 2006, 27:1114-1122.
10. Friedenstein A.J., et al. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970, 3:393-403.
11. Fukuda K. Progress in myocardial regeneration and cell transplantation. Circ. J. 2005, 69:1431-1446.
12. Giordano A., et al. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J. Cell. Physiol. 2007, 211:27-35.
13. Hu T.M., Chou T.C. The kinetics of thiol-mediated decomposition of S-nitrosothiols. AAPS J. 2006, 8:E485-E492.
14. Janssens M.Y., et al. Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation. Br. J. Cancer 1999, 79:1085-1089.
15. Jiang Y., et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 2002, 30:896-904.
16. Jones D.P. Redefining oxidative stress. Antioxid. Redox Signal. 2006, 8:1865-1879.
17. Kamihata H., et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1804-1810.
18. Kanno S., et al. Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 2004, 101:12277-12281.
19. Kinnaird T., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
20. Korbling M., Estrov Z. Adult stem cells for tissue repair-a new therapeutic concept?. N. Engl. J. Med. 2003, 349:570-582.
21. Maulik N. Reactive oxygen species drives myocardial angiogenesis?. Antioxid. Redox Signal. 2006, 8:2161-2168.
22. Mazo M., et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur. J. Heart Fail. 2008, 10:454-462.
23. Monastyrskaya E., et al. Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stress. Nitric Oxide 2002, 7:127-131.
24. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993, 329:2002-2012.
25. Nagaya N., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005, 112:1128-1135.
26. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992, 6:3051-3064.
27. Orlic D., et al. Stem cells for myocardial regeneration. Circ. Res. 2002, 91:1092-1102.
28. Park Y.K., et al. Nitric oxide donor, (+/-)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation. Mol. Pharmacol. 2008, 74:236-245.
29. Pittenger M.F., Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 2004, 95:9-20.
30. Pittenger M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
31. Planat-Benard V., et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res. 2004, 94:223-229.
32. Puissant B., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br. J. Haematol. 2005, 129:118-129.
33. Rebelatto C.K., et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp. Biol. Med. (Maywood) 2008, 233:901-913.
34. Rebelatto C.K., et al. Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents. Biochem. Biophys. Res. Commun. 2009, 378:456-461.
35. Sadat S., et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res. Commun. 2007, 363:674-679.
36. Schocken D.D., et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008, 117:2544-2565.
37. Strem B.M., et al. Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury. Cytotherapy 2005, 7:282-291.
38. Tang Y.L., et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann. Thorac. Surg. 2005, 80:229-236. discussion 236-7.
39. Tang J., et al. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur. J. Cardiothorac. Surg. 2006, 30:353-361.
40. Valina C., et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 2007, 28:2667-2677.
41. van der Bogt K.E., et al. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 2009, 87:642-652.
42. Wollert K.C., Drexler H. Clinical applications of stem cells for the heart. Circ. Res. 2005, 96:151-163.
43. Yang Y., Loscalzo J. S-nitrosoprotein formation and localization in endothelial cells. Proc. Natl Acad. Sci. USA 2005, 102:117-122.
44. Zai A., et al. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J. Clin. Invest. 1999, 103:393-399.
45. Zhang Y., Hogg N. S-Nitrosothiols: cellular formation and transport. Free Radic. Biol. Med. 2005, 38:831-838.
46. Zuk P.A., et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13:4279-4295.